🇺🇸 FDA
Patent

US 8178508

Methods of stimulating an immune response against prostate specific antigen

granted A61KA61K2035/124A61K2039/5154

Quick answer

US patent 8178508 (Methods of stimulating an immune response against prostate specific antigen) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 15 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2035/124, A61K2039/5154, A61K2039/5156, A61K2039/5158